Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,000
Closed -$8.7M 140
2017
Q4
$8.7M Buy
+50,000
New +$8.85M 0.29% 56
2017
Q2
Sell
-20,000
Closed -$3.28M 132
2017
Q1
$3.28M Buy
+20,000
New +$3.32M 0.19% 71
2016
Q2
Sell
-30,000
Closed -$4.5M 176
2016
Q1
$4.5M Sell
30,000
-20,000
-40% -$2.97M 0.39% 60
2015
Q4
$8.12M Buy
50,000
+48,720
+3,806% +$7.66M 0.6% 40
2015
Q3
$177K Buy
+1,280
New +$202K 0.01% 142
2013
Q4
Sell
-91,675
Closed -$10.3M 112
2013
Q3
$10.3M Buy
+91,675
New +$9.94M 0.83% 30

Other funds holding AMGN

Perceptive Advisors's AMGN Position: Q1 2018 in Review

Perceptive Advisors sold out of Amgen (AMGN) in Q1 2018, closing a stake of 50,000 shares — an estimated $8.7M sold.

Perceptive Advisors first reported a position in AMGN in Q3 2013 and held it in 6 quarters. The position peaked at $10.3M in Q3 2013. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Perceptive Advisors reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Perceptive Advisors sold 50,000 Amgen shares in Q1 2018, an estimated $8.7M.
  • Perceptive Advisors first reported a position in Amgen in Q3 2013 and held it in 6 quarters.
  • Perceptive Advisors's Amgen position peaked at $10.3M in Q3 2013.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Perceptive Advisors's 13F filing for Q1 2018, filed 15 May 2018.